- Home
- TWIN vs FBRX Comparison
TWIN vs FBRX Comparison
Compare TWIN & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- FBRX
- Stock Information
- Founded
- TWIN 1918
- FBRX N/A
- Country
- TWIN United States
- FBRX United States
- Employees
- TWIN N/A
- FBRX N/A
- Industry
- TWIN Industrial Machinery/Components
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- TWIN Industrials
- FBRX Health Care
- Exchange
- TWIN Nasdaq
- FBRX Nasdaq
- Market Cap
- TWIN 186.2M
- FBRX 154.5M
- IPO Year
- TWIN N/A
- FBRX N/A
- Fundamental
- Price
- TWIN $13.18
- FBRX $10.56
- Analyst Decision
- TWIN Strong Buy
- FBRX Strong Buy
- Analyst Count
- TWIN 1
- FBRX 3
- Target Price
- TWIN $12.00
- FBRX $68.00
- AVG Volume (30 Days)
- TWIN 69.1K
- FBRX 70.4K
- Earning Date
- TWIN 11-05-2025
- FBRX 11-13-2025
- Dividend Yield
- TWIN 1.21%
- FBRX N/A
- EPS Growth
- TWIN N/A
- FBRX N/A
- EPS
- TWIN N/A
- FBRX N/A
- Revenue
- TWIN $340,738,000.00
- FBRX N/A
- Revenue This Year
- TWIN $10.79
- FBRX N/A
- Revenue Next Year
- TWIN $8.43
- FBRX N/A
- P/E Ratio
- TWIN N/A
- FBRX N/A
- Revenue Growth
- TWIN 15.46
- FBRX N/A
- 52 Week Low
- TWIN $6.16
- FBRX $4.11
- 52 Week High
- TWIN $13.80
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- TWIN 69.93
- FBRX 43.42
- Support Level
- TWIN $12.79
- FBRX $10.65
- Resistance Level
- TWIN $13.80
- FBRX $11.57
- Average True Range (ATR)
- TWIN 0.68
- FBRX 0.85
- MACD
- TWIN 0.03
- FBRX -0.09
- Stochastic Oscillator
- TWIN 80.25
- FBRX 18.83
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).